Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Yunnan Baiyao To Get Investment From Ping An Life Insurance

This article was originally published in PharmAsia News

Executive Summary

Yunnan Baiyao Group has announced it will be issuing no more than 10 percent of its shares to Ping An Life Insurance Company of China. The latter's parent company Ping An Insurance Group says that with the deal still at the negotiation stage, it is not at liberty to reveal more details. However, analysts estimate that Yunnan Baiyao's enlistment of Ping An Life Insurance as an investor may raise roughly RMB1.6 billion. Industry insiders say the move represents Yunnan's strategy to expand its production capacity; the funds sought will be used for developing new products, likely to be in cosmetic medicine. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel